CASS Pharmaceuticals

Franklin, United States

CASS Pharmaceuticals is a medical company that provides rapid-acting insulin for diabetic patients.

$2.0M raised

Oct 2022

Seed

Biopharma Diabetes Health Care Medical Therapeutics

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about CASS Pharmaceuticals

How much funding has CASS Pharmaceuticals raised?

CASS Pharmaceuticals has raised $2.0M in total funding. The most recent round was Seed. The last funding was announced in October 2022.

Where is CASS Pharmaceuticals headquartered?

CASS Pharmaceuticals is headquartered in Franklin, United States.

What does CASS Pharmaceuticals do?

CASS Pharmaceuticals is a medical company that provides rapid-acting insulin for diabetic patients.

What stage is CASS Pharmaceuticals at?

CASS Pharmaceuticals is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 21, 2022.

MLA

"CASS Pharmaceuticals — Funding & Investors." VCBacked, October 21, 2022, https://www.vcbacked.co/company/cass-pharmaceuticals. Accessed July 2, 2026.

APA

VCBacked. (2022). CASS Pharmaceuticals — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/cass-pharmaceuticals

Wikipedia (cite web)

{{cite web |title=CASS Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/cass-pharmaceuticals |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 21, 2022.